Innovative Medicines Initiative
GPTKB entity
Properties (65)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Limited_Liability_Company
|
| gptkbp:addresses |
disease areas
|
| gptkbp:aimsTo |
improve patient access to new therapies
reduce time to market for new medicines |
| gptkbp:collaboratesWith |
academic institutions
pharmaceutical companies small and medium-sized enterprises |
| gptkbp:contributedTo |
health innovation
|
| gptkbp:encourages |
public-private collaboration
|
| gptkbp:facilitates |
knowledge sharing
|
| gptkbp:focusesOn |
healthcare challenges
|
| gptkbp:foundedIn |
2008
|
| gptkbp:funding |
gptkb:European_Union
|
| gptkbp:hasCollaboratedWith |
other initiatives
|
| gptkbp:hasEvents |
numerous successful projects
|
| gptkbp:hasFeature |
regulatory authorities
healthcare_professionals patient organizations |
| gptkbp:hasFocusOn |
biomedical research
|
| gptkbp:hasGoals |
accelerate the development of innovative medicines
1.6 billion euros enhance_competitiveness_of_European_industry |
| gptkbp:hasImpactOn |
public health
drug development process |
| gptkbp:hasPart |
gptkb:IMI2
gptkb:IMI2_JU |
| gptkbp:hasPublications |
reports
scientific articles |
| https://www.w3.org/2000/01/rdf-schema#label |
Innovative Medicines Initiative
|
| gptkbp:isActiveIn |
therapeutic areas
|
| gptkbp:isEvaluatedBy |
stakeholder feedback
independent experts |
| gptkbp:isFocusedOn |
patient-centered research
|
| gptkbp:isInvolvedIn |
clinical trials
cancer research health technology assessment mental health research digital health initiatives infectious disease research vaccine research data sharing initiatives regulatory science chronic disease research real-world evidence studies patient engagement initiatives antimicrobial resistance research rare disease research cardiovascular disease research metabolic disease research neurological disease research respiratory disease research biomarker_research |
| gptkbp:isLocatedIn |
gptkb:Brussels
|
| gptkbp:isManagedBy |
gptkb:European_Commission
gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations |
| gptkbp:isPartOf |
Horizon 2020
|
| gptkbp:isRecognizedBy |
international organizations
|
| gptkbp:isSupportedBy |
industry partners
philanthropic organizations EU_member_states |
| gptkbp:operatesIn |
Europe
|
| gptkbp:promotes |
collaborative research
|
| gptkbp:provides |
funding for projects
|
| gptkbp:supports |
research projects
training and education |